This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.

BMO Global Asset Management

April 2, 2020

April 2020 Fixed Income Market Update

The coronavirus and the measures taken to contain it have had a massive impact on individual lives, the economy and financial markets. While known to be large, significant uncertainty remains regarding just how dire the impacts will be.

Read More
Finimize

April 2, 2020

Laughing Stocks

Investors’ optimistic start to the year seems like a long time ago now. Global stocks fell 20% last quarter, losing around $20 trillion in value in what was their worst run since 2008. US government bonds, on the other hand, had one of their best quarters as investors clamored for their relative safety.

Read More
Interactive Advisors

April 2, 2020

Is The Bear Market Really Over?

After rising more than 20% in three days last week, the Dow technically entered a new bull market. In my opinion, that doesn’t mean the pain is over.

Read More
The Fly

April 2, 2020

Immunomedics Slide Pinned on FDA Facility Inspection Report

Immunomedics said recently that it was on target to obtain FDA approval for sacituzumab govitecan. While Cowen analyst Phil Nadeau remains confident the ASCENT trial will succeed and that sacituzumab will become standard of care in triple-negative breast cancer.

Read More
Edison

April 2, 2020

UK Sparks: Hays plans £200m equity raise

Recruitment group Hays has announced an equity placing, targeting gross proceeds of around £200m. It hopes this funding will provide additional liquidity buffer and allow the group to pursue organic growth opportunities with new and existing blue-chip clients once the markets stabilise. At end-March 2020, its net cash position was £35m versus £13.2m at end-December 2019. The company has committed borrowing facilities of £210m, of which around £165m is currently undrawn.

Read More
PIMCO

April 1, 2020

Economic Fallout: Here Comes Congress!

The massive U.S. stimulus bill that President Trump signed last week is designed to help individuals and businesses facing disruption caused by the coronavirus. However, Congress may have to do more in the months ahead.

Read More
Finimize

April 1, 2020

The Immune System

In a recent report, investment banking giant Goldman Sachs picked a handful of stocks that should vaccinate investors against the coronavirus pandemic – and even some that could help them come out stronger.

Read More
Page 1 of 124
1 2 3 4 5 6 7 8 9 10 11 124
trading top